
Brian Haggert, MS
Advertisement
Articles by Brian Haggert, MS

Advertisement
Latest Updated Articles
Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol ProductsPublished: February 1st 1996 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
3
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
4
ICYMI: Highlights From AACR 2025
5



